Robust antibody response after a third BNT162b2 vaccine compared to the second among immunocompromised and healthy individuals, a prospective longitudinal cohort study

PURPOSE: As protection from COVID-19 following two doses of the BNT162b2 vaccine showed a time dependent waning, a third (booster) dose was administrated. This study aims to compare the antibody response following the third dose versus the second and to evaluate post-booster seroconversion. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Shapiro Ben David, Shirley, Mizrahi, Barak, Rahamim-Cohen, Daniella, Supino-Rosin, Lia, Shahar, Arnon, Hermoni-Alon, Sharon, Fremder Sacerdote, Ariela, Irony, Angela, Lazar, Rachel, Kalkstein, Nir, Lustig, Yaniv, Indenbaum, Victoria, Landsberger, Daniel, Mizrahi-Reuveni, Miri, Shapira, Shirley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148186/
https://www.ncbi.nlm.nih.gov/pubmed/35641358
http://dx.doi.org/10.1016/j.vaccine.2022.05.051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148186/
https://www.ncbi.nlm.nih.gov/pubmed/35641358
http://dx.doi.org/10.1016/j.vaccine.2022.05.051

Ejemplares similares